Professional Documents
Culture Documents
Final Role of Tobacco Use in The Development and Progression of Leukoplakia1
Final Role of Tobacco Use in The Development and Progression of Leukoplakia1
Abstract: The increase in cancer mortality throughout the world justifies the study of its causes and development.
Tobacco use is implicated in the development of oral cancer, and oral leukoplakia as well. The aim of the study was
to give an overview of the connection between tobacco use and oral leukoplakia, considering the epidemiologic
patterns of tobacco habits, the prevalence of smoking in oral leukoplakia, and the effect of smoking on clinically
healthy oral mucosa. In the data, strong evidence has been found for the role of smoking in the development of both
oral cancer and oral leukoplakia.Cross-sectional studies show a higher prevalence rate of leukoplakia among
smokers, with a dose-response relationship between tobacco use and oral leukoplakia, and intervention studies show
a regression of the lesion after stopping the smoking habit.
1
more susceptible to the effects of chronic develop anywhere in the oral cavity. They
irritation. often have a uniform texture and color.3
Homogeneous leukoplakia: This type Oral mucosal lesions associated with betel
appears as smooth, white patches on the quid, areca nut and tobacco chewing habits.
mucous membranes of the mouth, tongue, or The term “quid” refers to a substance or
throat. The patches may vary in size and can mixture placed in the mouth or chewed,
1
remaining in contact with the mucosa. It 3. Leukoplakia patients:
typically contains one or both of the basic - Altered levels of specific biomarkers
ingredients: tobacco and/or areca nut, in raw or associated with inflammation and oxidative
processed forms. At a workshop in Kuala stress, such as interleukins (IL-6, IL-8), tumor
Lumpur, it was recommended to categorize necrosis factor-alpha (TNF-α), and
quids into clear delineations based on their malondialdehyde (MDA).
contents: areca nut quid, tobacco quid, and - Changes in salivary proteomic profiles,
tobacco and areca nut quid. Additionally, betel
including variations in the expression levels of
quid specifically refers to any quid wrapped in
proteins involved in cell adhesion,
a betel leaf, making it a distinct variety of
differentiation, and apoptosis.
quid.5
Biochemical changes of saliva in tobacco
4. Oral cancer patients:
chewers tobacco smokers, alcohol
- Elevated levels of various biomarkers
consumers, leukoplakia and oral cancer
associated with carcinogenesis, such as matrix
patients:The biochemical composition of
metalloproteinases (MMPs), vascular
saliva can be significantly altered in
endothelial growth factor (VEGF), and
individuals who engage in tobacco use, alcohol
epidermal growth factor receptor (EGFR).
consumption, and those with oral leukoplakia
or oral cancer. Here are some notable changes: - Altered expression of salivary microRNAs
(miRNAs) implicated in tumor progression
and metastasis.
1. Tobacco chewers/smokers:
- Decreased levels of certain tumor
- Elevated levels of nicotine and its
suppressor proteins, such as p53 and E-
metabolites may be present.
cadherin, and increased levels of oncoproteins
- Increased concentrations of cotinine, a
like c-Myc and Cyclin D1.
metabolite of nicotine, can be found.
- Reduced antioxidant capacity due to
These changes in salivary biochemistry reflect
decreased levels of antioxidants such as
the systemic effects of tobacco use, alcohol
glutathione and vitamins C and E.
consumption, and the pathophysiological
- Higher levels of certain enzymes linked to
processes associated with leukoplakia and oral
oxidative stress, such as myeloperoxidase.
cancer. Monitoring these biomarkers in saliva
may aid in early detection, risk assessment,
2. Alcohol consumers:
and monitoring of disease progression in
- Elevated levels of ethanol and its
affected individuals. 6
metabolites, such as acetaldehyde.
- Changes in the salivary microbiota,
Salivary IL-6 levels in oral leukoplakia with
including alterations in bacterial diversity and
dysplasia and its clinical relevance to
increased levels of potentially pathogenic
tobacco habits and periodontitis: The study
bacteria.
investigated IL-6 levels in patients with
- Decreased salivary flow rate, leading to dry
leukoplakia and coexisting periodontitis,
mouth (xerostomia) and reduced buffering
periodontitis patients without leukoplakia, and
capacity.
healthy controls. Results showed elevated IL-6
levels in leukoplakia with coexisting
1
periodontitis and periodontitis patients Mutations in p53 can lead to uncontrolled cell
compared to healthy controls (P < 0.001). growth and contribute to the development of
Within the leukoplakia group, IL-6 levels leukoplakia. P53 acts as a guardian of the
increased with dysplasia severity. Tobacco use genome, regulating cell cycle progression,
was associated with elevated salivary IL-6. IL- DNA repair, and apoptosis (programmed cell
6 was highlighted as a marker for leukoplakia death). When p53 function is impaired, cells
with dysplasia, emphasizing tobacco's with damaged DNA can accumulate,
independent risk.7 potentially leading to the formation of
Expression of bcl-2 and bax in chewing leukoplakia lesions and, in some cases,
tobacco-induced oral cancers and oral progression to cancer. Therefore, studying p53
lesions from India:The study investigated the expression and mutations in leukoplakia can
expression of apoptosis-regulating proteins provide insights into its pathogenesis and
bcl-2 and bax in oral squamous cell potential for malignant transformation.9
carcinomas (OSCC) and premalignant lesions
in Indian patients, primarily associated with REMISSION OF ORAL
chewing tobacco habits. They found PRECANCEROUS LESIONS OF
overexpression of cytoplasmic bcl-2 in 56% TOBACCO/ARECA NUT CHEWERS
and bax in 43% of OSCCs. Premalignant oral FOLLOWING ADMINISTRATION OF
lesions, including leukoplakias and potentially BETA-CAROTENE OR VITAMIN A, AND
malignant disorders, also exhibited aberrant MAINTENANCE OF THE PROTECTIVE
expression of bcl-2 (16%) and bax (55%). EFFECT
While some oral cancers demonstrated Research has shown that the administration of
concurrent deregulation of p53 and bcl-2 beta-carotene or vitamin A can lead to the
(30%), and p53, bcl-2, and bax (14%), none of remission of oral precancerous lesions in
the oral lesions showed deregulation of all tobacco and areca nut chewers. Furthermore,
three genes simultaneously. Interestingly, a the protective effect of these supplements can
subset of oral lesions showed overexpression be maintained over time. Beta-carotene and
of bax in the absence of p53 and bcl-2 vitamin A are known for their antioxidant
proteins. Positive nodal status correlated properties, which can help counteract the
significantly with bcl-2 expression and co- oxidative stress and DNA damage caused by
expression of p53 and bcl-2 in oral cancers. tobacco and areca nut consumption.
Survival analysis revealed higher survival rates Additionally, these supplements may support
in patients with p53-negative tumors compared immune function and promote the
to p53-positive tumors. These findings suggest differentiation of abnormal cells, contributing
frequent overexpression of apoptosis to the regression of precancerous lesions.
regulators in oral cancers and early events in However, it’s essential to consult a healthcare
oral carcinogenesis, highlighting the potential professional before starting any
roles of bcl-2 and p53 in tumorigenesis by supplementation regimen, as individual
evading apoptosis and allowing additional responses may vary, and proper dosing is
genetic alterations to accumulate.8 crucial for safety and efficacy.
Role of p53: The role of p53, a tumor Designs of intervention trials are based on
suppressor gene, in leukoplakia is significant. results from a multitude of disciplines. In this
1
study, a comparative analysis of various locations. Intervention trials were conducted to
chewing mixtures used by groups from assess the efficacy of beta-carotene and
different geographical locations (Guam, Peru, vitamin A in reducing micronucleated mucosal
Taiwan, the Philippines, and India) and their cells and remitting leukoplakias in tobacco-
link to oral cancer incidences was used to containing betel quid chewers. Results showed
trace the ingredients responsible for oral a decrease in micronucleated cells and
carcinogenesis among chewers. The leukoplakias following 3- to 6-month
usefulness of applying intermediate endpoints treatment, with inhibition of new leukoplakia
development. However, recurrence occurred
in intervention trials was examined by
upon cessation of treatment among continued
comparing the response of micronucleated
chewers. Maintenance of the protective effect
mucosal cells and oral leukoplakia of chewers
was attempted using high doses of
of tobacco-containing betel quids to the twice chemopreventive agents, with vitamin A
weekly administration of beta-carotene (180 (50,000 IU/week) showing better efficacy than
mg/week), vitamin A (100,000 IU/week or beta-carotene (60 mg/week) in sustaining
200,000 IU/week), and beta-carotene (180 reduced micronucleated cells over a 12-month
mg/week) plus vitamin A (100,000 IU/week). post-treatment period. It investigated the role
A reduced frequency of micro nucleated of p53 expression in patients with leukoplakia
mucosal cells and remission of leukoplakias and carcinoma of the tongue, focusing on its
resulted following a 3- to 6-month treatment. association with tobacco use.
The development of new leukoplakias was Immunohistochemistry was employed to
also inhibited. The various endpoints differed assess p53 expression. Notably, all patients
in degree and time course to the with leukoplakia of the tongue were male
administration of beta-carotene and vitamin A. tobacco users. This suggests a potential link
Following termination of the beta-carotene or between tobacco use and the leukoplakia.
vitamin A administration, micro nucleated
cells and leukoplakia recurred in the oral
cavity of chewers who continued this habit
throughout the trial period. Attempts were
made to maintain the protective effect
achieved by the treatment with relatively high
doses of the chemo preventive agents. Vitamin
A given at a level of 50,000 IU/week was able
to keep the frequency of micro nucleated
mucosal cells at low levels for at least a 12-
month post-treatment period, whereas beta-
carotene administered at 60 mg/week was less
effective in maintaining the protective effect.10
CONCLUSION
This study explored the association between
chewing mixtures and oral cancer incidence
among groups from various geographical
1
5.Girja KP, Sundharam BS, Krishnan PA, Devi
CS. Biochemical changes of saliva in tobacco
chewers tobacco smokers, alcohol consumers,
leukoplakia and oral cancer patients. Indian J
Dent Res. 2002 Apr-Jun;13(2):102-7. PMID:
12420576.
1
1